408 Using yeast as a model, synthetic cannabinoids consumption might be a risk factor on the onset of Parkinson’s Disease

Carla Filipa da Silva Ferreira
Centro de investigação interdisciplinar Egas Moniz
cferreira@egasmoniz.edu.pt
Sandra Tenreiro, Alexandre Quintas
CEDOC – Chronic Diseases Research Center, Centro de investigação interdisciplinar Egas Moniz